Motus GI Holdings, Inc.
DelistedCIK 1686850fmd_1REDYBGDPEZB7RNYTXCYYPJ77SManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2017 to Mar 31, 2024, 29 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 0 | 0 | 1 | 0 |
| Rental revenue | – | – | – | 0 | 0 | 0 | – |
| Cost of revenue | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | – | (0) | (0) | 0 | 0 | 0 | 0 |
| Research and development | 4 | 6 | 9 | 6 | 5 | 6 | 3 |
| Selling, general and administrative | – | – | – | 13 | 12 | 12 | 8 |
| Total operating expenses | 13 | 19 | 24 | 19 | – | – | – |
| Operating income | (13) | (19) | (23) | (19) | (18) | (18) | (12) |
| Interest expense | – | – | 0 | 0 | 0 | 1 | 1 |
| Income before taxes | (13) | (22) | (23) | (19) | – | – | – |
| Income tax expense | – | – | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | (19) | – | – | – |
| Net income | (13) | (22) | (23) | (19) | (19) | (19) | (13) |
| Net income to common shareholders | – | – | – | (19) | (25) | (19) | – |